Skip to main content
Log in

Transforming growth factor beta may act as an autocrine-survival-promoting factor for transformed trophoblasts

  • Cytokines/Growth Factors/Adhesion Factors
  • Published:
In Vitro Cellular & Developmental Biology - Animal Aims and scope Submit manuscript

Summary

Using five trophoblast cell lines of different differentiation status, we have shown that trophoblasts could constitutively release the transforming growth factor beta-1 (TGFβ1), but not TGFβ2. Treatment of the human tumorigenic, TL, and BeWo cells with a differentiating agent and a potent protein kinase C activator—the tumor-promoting agent—or the JEG-3 cells with cholera toxin—a potent cyclic adenosine 3′:5′ monophosphate (cAMP) inducer—or its analogue 8-bromo-cAMP, potentiates TGFβ production, but the two signaling pathways appear to be mutually exclusive. Surprisingly, the JAR cell line failed to respond to either type of TGFβ activator. Based on reverse transcriptase (RT)-polymerase chain reaction (PCR), it was found that only the JAR cell line expressed messenger ribonucleic acid for decorin, a natural inhibitor of TGFβ, and none of the cell lines had detectable protein expression as determined by immunocytochemical studies. The cell number in cultures with decorin was invariably lesser than in those without decorin under serum-free conditions for all the cell lines tested. These results suggest that TGFβ may act as an autocrine-survival factor for transformed trophoblasts by allowing the cells to survive longer under a microenvironment which is not favorable for growth. Lastly, our results indicate that decorin, acting in a paracrine manner, may also play an important negative regulatory role in the development of transformed trophoblasts by sequestering TGFβ, thereby preventing its action.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Altomonte, M.; Montagner, R.; Fonsatti, E., et al. Expression and structural features of endoglin (CD105), a transforming growth factor β1 and β3 binding protein, in human melanoma. Br. J. Cancer 74:1586–1591 1996.

    PubMed  CAS  Google Scholar 

  • Asundi, V. K.; Dreher, K. L. Molecular characterization of vascular smooth muscle decorin: deduced core protein structure and regulation of gene expression. Eur. J. Cell Biol. 59:314–321; 1992.

    PubMed  CAS  Google Scholar 

  • Böl, G. F.; Gros, C.; Hülster, A., et al. Phorbol ester-induced sensitisation of adenylyl cyclase type II is related to phosphorylation of threonine 1057. Biochem. Biophys. Res. Commun. 237:251–256; 1997.

    Article  PubMed  Google Scholar 

  • Burnside, J.; Nagelberg, S. B.; Lippman, S. S., et al. Differential regulation of hCGα and β subunit in RNAs in JEG-3 choriocarcinoma cells by 8-bromo-cAMP. J. Biol. Chem. 260:12,705–12,709; 1985.

    CAS  Google Scholar 

  • Caniggia, I.; Taylor, C. V.; Ritchie, J. W. K., et al. Endoglin regulates trophoblast differentiation along the invasive pathway in human placental villous explants. Endocrinology 138:4977–4988; 1997.

    Article  PubMed  CAS  Google Scholar 

  • Chantry, D.; Turne, M.; Abney, E., et al. Modulation of cytokine production by transforming growth factor-β1. J. Immunol. 142:4295–4300; 1989.

    PubMed  CAS  Google Scholar 

  • Chou, J. Y. Effects of adenosine cyclic nucleotides on the synthesis of human chorionic gonadotropin in transformed human placental cells. Cancer Res. 40:4025–4030; 1980.

    PubMed  CAS  Google Scholar 

  • Dyne, K. M.; Valli, M.; Forlino, A., et al. Deficient expression of the small proteoglycan decorin in a case of severe/lethal osteogenesis imperfecta. Am. J. Med. Genet. 63:161–166; 1996.

    Article  PubMed  CAS  Google Scholar 

  • Ganguly, N. K.; Kaur, T. Mechanism of action of cholera toxin & other toxins. Indian J. Med. Res. 104:28–37; 1996.

    PubMed  CAS  Google Scholar 

  • Graham, C. H.; Connelly, I.; MacDougall, J. R., et al. Resistance of malignant trophoblast cells to both the anti-proliferative and anti-invasive effects of transforming growth factor-β. Exp. Cell Res. 214:93–99; 1994.

    Article  PubMed  CAS  Google Scholar 

  • Graham, C. H.; Lala, P. K. Mechanisms of placental invasion of the uterus and their control. Biochem. Cell Biol. 70:867–874; 1992.

    PubMed  CAS  Google Scholar 

  • Graham, C. H.; Lysiak, J. J.; McCrae, K. R., et al. Localization of transforming growth factor-β at the human fetal-maternal interface: role in trophoblast growth and differentiation. Biol. Reprod. 46:561–572; 1992

    Article  PubMed  CAS  Google Scholar 

  • Grande, J. P. Role of transforming growth factor-beta in tissue injury and repair. Proc. Soc. Exp. Biol. Med. 214:27–40; 1997.

    PubMed  CAS  Google Scholar 

  • Ho, C. K.; Chiang, H.; Li, S. Y., et al. Establishment and characterization of a tumorigenic trophoblast-like cell line from a human placenta. Cancer Res. 47:3220–3224; 1987.

    PubMed  CAS  Google Scholar 

  • Ho, C. K.; Wang, C. C.; Li, S. Y., et al. Characterization of a human tumorigenic poorly differentiated trophoblast cell line. In Vitro Cell Dev. Biol. 30A:415–417; 1994.

    Article  CAS  Google Scholar 

  • Hurley, J. H. Structure, mechanism, and regulation of mammalian adenyl cyclase. J. Biol. Chem. 274:7599–7602; 1999.

    Article  PubMed  CAS  Google Scholar 

  • Iozzo, R. V. The biology of the small leucine-rich proteoglycans. J. Biol. Chem. 274:18,843–18,846; 1999.

    CAS  Google Scholar 

  • Iozzo, R. V.; Moscatello, D. K.; McQuillan, D. J., et al Decorin is a biological ligand for the epidermal growth factor receptor. J. Biol. Chem. 274:4489–4492; 1999.

    Article  PubMed  CAS  Google Scholar 

  • Koli, K.; Keski-Oja, J. Transforming growth factor-beta system and its regulation by members of the steroid-thyroid hormone superfamily. Adv. Cancer Res. 70:63–94; 1996.

    Article  PubMed  CAS  Google Scholar 

  • Krusius, T.; Ruoslahti, E. Primary structure of an extracellular matrix proteoglycan core protein deduced from cloned cDNA. Proc. Natl. Acad. Sci. USA 83:768307687; 1986.

    Article  Google Scholar 

  • Laiho, M.; Keski-Oja, J. Growth factors in the regulation of pericellular proteolysis: a review. Cancer Res. 49:2533–2553; 1989.

    PubMed  CAS  Google Scholar 

  • Lang, A. K.; Searle, R. F. The immunomodulatory activity of human amniotic fluid can be correlated with transforming growth factor-beta 1 (TGF-β1) and β2 activity. Clin. Exp. Immunol. 97:158–163; 1994.

    Article  PubMed  CAS  Google Scholar 

  • Lastres, P.; Letamendia, A.; Zhang, H., et al. Endoglin modulates cellular responses to TGF-β1. J. Cell Biol. 133:1109–1121; 1996.

    Article  PubMed  CAS  Google Scholar 

  • Leof, E. B.; Porper, J. A.; Goustin, A. S., et al. Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor-β: a proposed model for indirect mitogenesis involving autocrine activity. Proc. Natl. Acad. Sci. USA 83:2453–2457; 1986.

    Article  PubMed  CAS  Google Scholar 

  • Lin, H. Y.; Moustakas, A. TGF-beta receptors: structure and function. Cell. Mol. Biol. 40:337–349; 1994.

    PubMed  CAS  Google Scholar 

  • Loke, Y. W. Experimenting with human extravillous trophoblast: a personal view. Am. J. Reprod. Immunol. 24:22–28; 1990.

    PubMed  CAS  Google Scholar 

  • Lysiak, J. J.; Hunt, J.; Pringle, G. A., et al. Localization of transforming growth factor β and its natural inhibitor decorin in the human placenta and decidua throughout gestation. Placenta 16:221–231; 1995.

    Article  PubMed  CAS  Google Scholar 

  • Massague, J. TGFβ signaling: receptors, transducers, and Mad proteins. Cell 85:947–950; 1996.

    Article  PubMed  CAS  Google Scholar 

  • McCartney-Francis, N. L.; Wahl, S. M. Transforming growth factor beta: a matter of life and death. J. Leukoc. Biol. 55:401–409; 1994.

    PubMed  CAS  Google Scholar 

  • Mitchell, E. J.; Fitz-Gibbon, L.; O'Connor-McCourt M. D. Subtypes of betaglycan and of type I and type II transforming growth factor-β (TGF-β) receptors with different affinities for TGF-β1 and TGF-β2 are exhibited by human placental trophoblast cells. J. Cell Physiol. 150:334–343; 1992.

    Article  PubMed  CAS  Google Scholar 

  • Morrish, D. W.; Dakour, J.; Li, H. Functional regulation of human trophoblast differentiation. J. Reprod. Immunol. 39:179–195; 1998.

    Article  PubMed  CAS  Google Scholar 

  • Mossman, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J. Immunol. Methods 65:55; 1983.

    Article  Google Scholar 

  • Nash, M. A.; Loercher, A. E.; Freedman, R. S. In vitro growth inhibition of ovarian cancer cells by decorin: synergism of action between decorin and carboplatin. Cancer Res. 59:6192–6196; 1999.

    PubMed  CAS  Google Scholar 

  • Ritvos, O.; ErÄmaa, M. Adenosine 3′,5′-monophosphate and phorbol ester induce transforming growth factor-β1 messenger ribonucleic acid levels in choriocarcinoma cells. Endocrinology 129:2240–2245; 1991.

    Article  PubMed  CAS  Google Scholar 

  • Roberts, A. B.; Anzano, M. A.; Wakefield, L. M., et al. Type β transforming growth factor: a bifunctional regulator of cellular growth. Proc. Natl. Acad. Sci. USA 82:119–123; 1985.

    Article  PubMed  CAS  Google Scholar 

  • Roberts, A. B.; Sporn, M. B. Physiological actions and clinical applications of transforming growth factor-β (TGF-β). Growth Factors 8:1–9; 1993.

    Article  PubMed  CAS  Google Scholar 

  • Santra, M.; Skoroski, T.; Calabretta, B., et al. De novo decorin gene expression suppresses the malignant phenotype in human colon cancer cells. Proc. Natl. Acad. Sci. USA 92:7016–7020; 1995.

    Article  PubMed  CAS  Google Scholar 

  • Shibamoto, S.; Hayakawa, M.; Hori, T. et al. Hepatocyte growth factor and transforming factor-β stimulate both cell growth and migration of human gastric adenocarcinoma cells. Cell Struct. Funct. 17:185–190; 1992

    Article  PubMed  CAS  Google Scholar 

  • Ständer, M.; Naumann, U.; Wick, W., et al. Transforming growth factor-β and p-21: multiple molecular targets of decorin-mediated suppression of neoplastic growth. Cell Tissue Res. 296:221–227; 1999.

    Article  PubMed  Google Scholar 

  • Yamaguchi, Y.; Mann, D. M.; Ruoslahti, E. Negative regulation of transforming growth factor-β by the proteoglycan decorin. Nature 346:281–284; 1990.

    Article  PubMed  CAS  Google Scholar 

  • Yamashita, H.; Ichijo, H.; Grimsby, S., et al. Endoglin forms a heteromeric complex with the signaling receptors for transforming growth factor-β. J. Biol. Chem. 269:1995–2001; 1994.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chi-Kuan Ho.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ho, CK., Au, LC., Peng, HJ. et al. Transforming growth factor beta may act as an autocrine-survival-promoting factor for transformed trophoblasts. In Vitro Cell.Dev.Biol.-Animal 37, 245–250 (2001). https://doi.org/10.1007/BF02577537

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02577537

Key words

Navigation